Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

The industry's leading manufacturers are Fujifilm Holding Corporation (CDI), Ncardia and Sumitomo Dainippon Pharma, which accounted for 39.31 percent, 20.24 percent and 13.67 percent of revenue, respectively.

Download FREE Sample of this Report @ https://www.24lifesciences.com/report-sample/4538-global-covid-impact-induced-pluripotent-stem-cells-2020-2026-794

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Induced Pluripotent Stem Cells (iPSCs) market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Induced Pluripotent Stem Cells (iPSCs) industry.

Based on our recent survey, we have several different scenarios about the Induced Pluripotent Stem Cells (iPSCs) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 81 million in 2019. The market size of Induced Pluripotent Stem Cells (iPSCs) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Induced Pluripotent Stem Cells (iPSCs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Induced Pluripotent Stem Cells (iPSCs) market in terms of revenue.

Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells (iPSCs) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Induced Pluripotent Stem Cells (iPSCs) market, covering important regions, viz, North America, Europe, China, Japan and Brazil. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Induced Pluripotent Stem Cells (iPSCs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Induced Pluripotent Stem Cells (iPSCs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Induced Pluripotent Stem Cells (iPSCs) market.

The following players are covered in this report:

Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL

Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type

Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.

Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application

Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others

Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.

Get the Complete Report & TOC @ https://www.24lifesciences.com/market-reports/global-covid-impact-induced-pluripotent-stem-cells-2020-2026-794-4538
Table of content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human iPSCs
1.4.3 Mouse iPSCs
1.5 Market by Application
1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2026
1.5.2 Academic Research
1.5.3 Drug Development and Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Induced Pluripotent Stem Cells (iPSCs) Industry Impact
1.6.1 How the Covid-19 is Affecting the Induced Pluripotent Stem Cells (iPSCs) Industry
1.6.1.1 Induced Pluripotent Stem Cells (iPSCs) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Induced Pluripotent Stem Cells (iPSCs) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Induced Pluripotent Stem Cells (iPSCs) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by

CONTACT US:
North Main Road Koregaon Park, Pune, India - 411001.
International: +1(646)-781-7170
Asia: +91 9169164321
Email: help@24lifesciences.com